816 related articles for article (PubMed ID: 8656173)
21. Insulin in the early management of diabetic complications.
Miles JM
J Assoc Physicians India; 2003 May; 51():501-5. PubMed ID: 12974435
[TBL] [Abstract][Full Text] [Related]
22. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
Choy M; Lam S
Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
[TBL] [Abstract][Full Text] [Related]
23. Metformin: an antihyperglycemic agent for treatment of type II diabetes.
Melchior WR; Jaber LA
Ann Pharmacother; 1996 Feb; 30(2):158-64. PubMed ID: 8835050
[TBL] [Abstract][Full Text] [Related]
24. Metformin.
Bailey CJ; Turner RC
N Engl J Med; 1996 Feb; 334(9):574-9. PubMed ID: 8569826
[No Abstract] [Full Text] [Related]
25. An overview of metformin in the treatment of type 2 diabetes mellitus.
Davidson MB; Peters AL
Am J Med; 1997 Jan; 102(1):99-110. PubMed ID: 9209206
[TBL] [Abstract][Full Text] [Related]
26. Insulin: either alone or combined with oral hypoglycemic agents.
Firth RG
Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
Laurenti O; Bravi MC; Faldetta MC; De Mattia G
Clin Ter; 1992 Mar; 140(3):259-63. PubMed ID: 1568370
[TBL] [Abstract][Full Text] [Related]
28. [Oral antidiabetic agents: recent aspects].
Keller U; Berger W
Schweiz Med Wochenschr; 1983 Apr; 113(17):645-50. PubMed ID: 6191388
[TBL] [Abstract][Full Text] [Related]
29. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
Berger W
Horm Metab Res Suppl; 1985; 15():111-5. PubMed ID: 3865878
[TBL] [Abstract][Full Text] [Related]
30. [Drug therapy of type-II diabetes: tablets, insulin or a combination of these].
Diem P
Schweiz Rundsch Med Prax; 1994 Jan; 83(3):68-71. PubMed ID: 8296132
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic treatment options for non-insulin-dependent diabetes mellitus.
Tan GH; Nelson RL
Mayo Clin Proc; 1996 Aug; 71(8):763-8. PubMed ID: 8691897
[TBL] [Abstract][Full Text] [Related]
32. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
Mehnert H
Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320
[No Abstract] [Full Text] [Related]
33. Metformin and the sulphonylureas: the comparative risk.
Campbell IW
Horm Metab Res Suppl; 1985; 15():105-11. PubMed ID: 3935560
[TBL] [Abstract][Full Text] [Related]
34. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
Fövényi J
Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
[No Abstract] [Full Text] [Related]
35. The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis.
Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Nutter B; Jain A; Atreja A; Zimmerman RS
Diabet Med; 2012 Aug; 29(8):1029-35. PubMed ID: 22248043
[TBL] [Abstract][Full Text] [Related]
36. [Knack of treatment with oral hypoglycemic drugs in the elderly].
Komatsu M; Hashizume K
Nihon Rinsho; 2006 Jan; 64(1):93-8. PubMed ID: 16408454
[TBL] [Abstract][Full Text] [Related]
37. Metformin: a new oral biguanide.
Campbell RK; White JR; Saulie BA
Clin Ther; 1996; 18(3):360-71; discussion 359. PubMed ID: 8829014
[TBL] [Abstract][Full Text] [Related]
38. [Adverse effect of biguanides].
Yamasaki Y; Kuroda A
Nihon Rinsho; 2002 Sep; 60 Suppl 9():389-92. PubMed ID: 12387023
[No Abstract] [Full Text] [Related]
39. [Value of biguanide in therapy of diabetes mellitus].
Haupt E; Panten U
Med Klin (Munich); 1997 Aug; 92(8):472-9, 505. PubMed ID: 9340472
[TBL] [Abstract][Full Text] [Related]
40. Biguanides and NIDDM.
Bailey CJ
Diabetes Care; 1992 Jun; 15(6):755-72. PubMed ID: 1600835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
